Resistance to Activated Protein C in Nine Thrombophilic Families: Interference in a Protein S Functional Assay

Summary

Nine thrombophilic patients who had had previous diagnoses of functional protein S deficiency were reinvestigated. The functional protein S assays gave dose-response curves that were not parallel to those of the reference plasma. The same pattern was true for approximately half of the first-degree relatives of the propositi. When protein S was extracted from the plasma of the patients by immunoabsorption, it had a normal ratio of functional activity to immunologic concentration. Restriction fragment length polymorphism analysis, informative in one family, showed no linkage between the protein S gene marker and the abnormal behavior of the protein S functional assay. All the propositi and 23/36 first-degree relatives were resistant to the prolongation of activated partial thromboplastin time induced by activated protein C. Furthermore, there was striking concordance in all patients and relatives between the abnormal pattern of the protein S functional assay and resistance to activated protein C. We conclude that a plasma-based functional protein S assay is sensitive to activated protein C resistance and this may lead to spuriously low results in the assay. In agreement with the results of others, this study indicates that resistance to activated protein C is a frequent hemostatic defect in selected thrombophilic populations.

• References

• 1 Dahlbäck B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61
• 2 Engesser L, Broekmans AW, Briet E, Brommer EJP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-682
• 3 Preda L, Tripodi A, Valsecchi C, Lombardi A, Finotto E, Mannucci PM. A prothrombin time-based functional assay of protein S. Thromb Res 1990; 60: 19-32
• 4 D’Angelo A, Viganò S, Esmon CT, Comp PC. Acquired deficiencies of protein S: protein S activity during anticoagulation in liver disease and in disseminated intravascular coagulation. J Clin Invest 1988; 81: 1445-1454
• 5 Wolf M, Boyer-Neumann C, Martinoli JL, Leroy-Matheron C, Amiral J, Meyer D, Larrieu MJ. A new functional assay for human protein S activity using activated factor V as substrate. Thromb Haemost 1989; 62: 1144-1145
• 6 Mannucci PM, Valsecchi C, Krachmalnicoff A, Faioni EM, Tripodi A. Familial dysfunction of protein S. Thromb Haemost 1989; 62: 763-766
• 7 Boyer-Neumann C, Bertina RM, Tripodi A, D’Angelo A, Wolf M, Viganò-D’ AngeloS, Mannucci Pm, Meyer D, Larrieu MJ. Comparison of functional assays for protein S: European collaborative study of patients with congenital and acquired deficiencies. Thromb Haemost. 1993 in press
• 8 Dahlbӓck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
• 9 D’Angelo ViganòS, Tombesi S, Marcovina S, Albertini A, Della ValleP, D’Angelo A. Monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for the measurement of vitamin K-dependent protein S: the effect of antibody immunoreactivity on plasma protein S antigen determinations. Thromb Haemost 1992; 67: 631-638
• 10 Faioni EM, Franchi F, Krachmalnicoff A, Valsecchi C, Viganò GL, Remuzzi G, Mannucci PM. Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma. Thromb Haemost 1991; 66: 420-425
• 11 Diepstraten CM, van Amstel PloosJK, Reitsma PH, Bertina RM. A CCA/CCG neutral dimorphism in the codon for Pro 626 of the human protein S gene PSα (PROS1). Nucl Ac Res 1991; 19: 5091-5094
• 12 Marchetti G, Legnani C, Patracchini P, Gemmati D, Ferrati M, Palareti G, Coccheri S, Bernardi F. Study of a protein S gene polymorphism at DNA and mRNA level in a family with symptomatic protein S deficiency. Br J Haematol 1993; 85: 173-175
• 13 Svensson PJ, Dahlback B. Novel mechanisms for thrombosis characterized by poor anticoagulant response to activated protein C constitutes a major cause of thrombophilia. Thromb Haemostas. 1993 69. abs. 1632
• 14 Griffin JH, Evatt B, Widerman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993